placeholder image
J. M. Davis All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Estimated 2023-2024 COVID-19 vaccine effectiveness in adults
    JAMA network open. 2025
  • Protection of two and three mRNA vaccine doses against severe outcomes among adults hospitalized with COVID-19--VISION Network, August 2021 to March 2022
    Journal of Infectious Diseases. 2023
  • Relations of current and past cancer with severe outcomes among 104,590 hospitalized COVID-19 patients: the COVID EHR cohort at the University of Wisconsin
    Cancer Epidemiology, Biomarkers and Prevention. 2023
  • Smoking status, nicotine medication, vaccination, and COVID-19 hospital outcomes: findings from the COVID EHR cohort at the University of Wisconsin (CEC-UW) study
    Nicotine & tobacco research. 2023
  • Effectiveness of homologous and heterologous COVID-19 booster doses following 1 Ad.26.COV2.S (Janssen (Johnson & Johnson)) vaccine dose against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults - VISION Network, 10 states, December 2021-March 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Contact
    full name
  • J. M. Davis
  • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration